首页> 外文期刊>Journal of clinical gastroenterology >Portal and mesenteric vein thrombosis in a patient heterozygous for a mutation (Arg506-->Gln) in the factor V gen (factor V Leiden).
【24h】

Portal and mesenteric vein thrombosis in a patient heterozygous for a mutation (Arg506-->Gln) in the factor V gen (factor V Leiden).

机译:患者杂合子中门静脉和肠系膜静脉血栓形成,突变为Arg因子V gen(因子V Leiden)(Arg506-> Gln)。

获取原文
获取原文并翻译 | 示例
       
  • Gln) in the factor V gen (factor V Leiden).','sina');">新浪微博
  • QQ群
  • QQ空间
-->

    摘要

    In 30-50% of patients with portal thrombosis, no underlying etiology is found. The recent reports of new hereditary clotting defects are contributing to the understanding of this problem, but they only justify a small number of idiopathic cases. Instead, anticoagulant protein C resistance, caused by a mutation in the V factor gene, appears to be at least 10 times more common than any of the other known inherited deficiencies of anticoagulant proteins. In spite of that, extensive thrombosis of portomesenteric or hepatic venous circulation has been rarely described in this hereditary clotting defect. We report a typical case of familial and recidivant deep vein thrombosis in a young man heterozygous for the factor V Leiden mutation (Arg506-Gln), who developed an acute portal and mesenteric vein thrombosis. The patient was discharged with an oral anticoagulant treatment and remains asymptomatic 2 years later. In conclusion, the high prevalence of the factor V Leiden in young and aged patients with idiopathic vein thrombosis and the case here described makes it obligatory to consider this disorder in patients with portal and/or mesenteric vein thrombosis, especially in those without evident etiology.
    机译:在30-50%的门静脉血栓形成患者中,未发现潜在的病因。最近关于新的遗传性凝结缺陷的报道有助于对该问题的理解,但它们仅证明了少数特发性病例的合理性。取而代之的是,由V因子基因突变引起的抗凝蛋白C抵抗似乎比任何其他已知的抗凝蛋白遗传缺陷至少常见10倍。尽管如此,在这种遗传性凝血缺陷中很少有人描述过肠系膜或肝静脉循环的广泛血栓形成。我们报告了一个典型的家族性和附属性深静脉血栓形成的典型案例,该杂合子是一名年轻的男子,因杂合子V莱顿突变(Arg506-Gln)而发展为急性门脉和肠系膜静脉血栓形成。患者经口服抗凝治疗后出院,两年后仍无症状。总之,在年轻和老年特发性静脉血栓形成的患者中,V Leiden因子的高患病率以及此处描述的病例使得必须在门静脉和/或肠系膜静脉血栓形成的患者中考虑这种疾病,尤其是在病因不明确的患者中。

    著录项

    相似文献

    • 外文文献
    • 中文文献
    • 专利
    获取原文

    客服邮箱:kefu@zhangqiaokeyan.com

    京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
    • 客服微信

    • 服务号